Explore by goal
Pain Management
Explore clinician-guided pain and inflammation pathways, including low-dose naltrexone and select recovery programs when appropriate.
What to consider
Pain and inflammation pathways
Explore clinician-guided pain and inflammation pathways, including low-dose naltrexone and select recovery programs when appropriate.
0 programs
Pain Management programs
Consider This
Learn before you choose
FAQ
Questions worth asking
Is low-dose naltrexone FDA approved for chronic pain?
No. Naltrexone is FDA approved for opioid- and alcohol-related indications at standard doses; low-dose use for chronic pain or inflammation-related conditions is off label.
Can LDN be used with opioid medication?
Naltrexone blocks opioid receptors and can create serious problems for people using opioid medications or with opioid dependence. A clinician must review all prescriptions, nonprescription products and recent opioid exposure.
How strong is the evidence for LDN and pain?
The evidence is evolving and varies by condition. A recent randomized-trial meta-analysis found mixed results overall, with a signal in fibromyalgia but increased adverse events versus placebo. It should not be marketed as a proven universal pain treatment.
Does online LDN care replace a pain evaluation?
No. New weakness, loss of bowel or bladder control, chest pain, severe injury, fever with pain or other red flags need urgent or in-person assessment.
Authoritative starting points
Private clinician review
Find the path that fits the whole picture.
Program pages are educational. Eligibility, treatment, route and availability are determined only after an independent clinical evaluation.